|
EP0368684B2
(en)
|
1988-11-11 |
2004-09-29 |
Medical Research Council |
Cloning immunoglobulin variable domain sequences.
|
|
US5399346A
(en)
|
1989-06-14 |
1995-03-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Gene therapy
|
|
SE509359C2
(sv)
|
1989-08-01 |
1999-01-18 |
Cemu Bioteknik Ab |
Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
|
|
EP0542810A1
(en)
|
1990-08-02 |
1993-05-26 |
B.R. Centre Limited |
Methods for the production of proteins with a desired function
|
|
US5440021A
(en)
|
1991-03-29 |
1995-08-08 |
Chuntharapai; Anan |
Antibodies to human IL-8 type B receptor
|
|
CA2105998C
(en)
|
1991-03-29 |
2003-05-13 |
James Lee |
Human pf4a receptors and their use
|
|
US5374506A
(en)
|
1991-09-13 |
1994-12-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Amino acid sequence for a functional human interleukin-8 receptor
|
|
DE69334095T2
(de)
|
1992-07-17 |
2007-04-12 |
Dana-Farber Cancer Institute, Boston |
Verfahren zur intrazellulären Bindung von zielgerichteten Molekülen
|
|
AU701578B2
(en)
|
1992-08-21 |
1999-02-04 |
Vrije Universiteit Brussel |
Immunoglobulins devoid of light chains
|
|
EP0702721B1
(en)
|
1993-06-09 |
2001-01-03 |
Unilever N.V. |
Process for producing fusion proteins comprising scfv fragments by a transformed mould
|
|
US6091639A
(en)
|
1993-08-27 |
2000-07-18 |
Kabushiki Kaisha Toshiba |
Non-volatile semiconductor memory device and data programming method
|
|
US6448379B1
(en)
|
1993-09-14 |
2002-09-10 |
Chiron Corporation |
IL8 inhibitors
|
|
US5595756A
(en)
*
|
1993-12-22 |
1997-01-21 |
Inex Pharmaceuticals Corporation |
Liposomal compositions for enhanced retention of bioactive agents
|
|
WO1995022618A1
(en)
|
1994-02-22 |
1995-08-24 |
Dana-Farber Cancer Institute |
Nucleic acid delivery system, method of synthesis and uses thereof
|
|
EP0739981A1
(en)
|
1995-04-25 |
1996-10-30 |
Vrije Universiteit Brussel |
Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
|
|
AU7298398A
(en)
|
1996-11-19 |
1998-06-10 |
Sangstat Medical Corporation |
Enhanced effects for hapten conjugated therapeutics
|
|
US6329516B1
(en)
|
1997-04-28 |
2001-12-11 |
Fmc Corporation |
Lepidopteran GABA-gated chloride channels
|
|
BR9813276A
(pt)
|
1997-10-27 |
2000-08-22 |
Unilever Nv |
Proteìna multivalente de ligação de antìgeno, sequências de nucleotìdeos, vetor de expressão, célula hospedeira, processo para preparação de proteìna multivalente de ligação de antìgeno, e, uso da mesma
|
|
AU3295299A
(en)
|
1998-02-19 |
1999-09-06 |
Xcyte Therapies, Inc. |
Compositions and methods for regulating lymphocyte activation
|
|
EP0967284A1
(en)
|
1998-05-28 |
1999-12-29 |
Pfizer Limited |
Phosphodiesterases
|
|
GB9824632D0
(en)
|
1998-11-10 |
1999-01-06 |
Celltech Therapeutics Ltd |
Biological compounds
|
|
CA2361678A1
(en)
|
1999-02-05 |
2000-08-10 |
Rijksuniversiteit Leiden |
Method of modulating metabolite biosynthesis in recombinant cells
|
|
US6617122B1
(en)
|
1999-03-15 |
2003-09-09 |
Xenon Genetics, Inc. |
Process for identifying modulators of ABC1 activity
|
|
SG121853A1
(en)
|
1999-06-18 |
2006-05-26 |
Cv Therapeutics Inc |
Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abc1
|
|
EP1198572A2
(en)
|
1999-08-02 |
2002-04-24 |
Keygene N.V. |
Method for generating cgmmv resistant plants, genetic constructs, and obtained cgmmv-resistant plants
|
|
US20040214783A1
(en)
|
2002-05-08 |
2004-10-28 |
Terman David S. |
Compositions and methods for treatment of neoplastic disease
|
|
GB9922124D0
(en)
|
1999-09-17 |
1999-11-17 |
Pfizer Ltd |
Phosphodiesterase enzymes
|
|
DE19955408A1
(de)
|
1999-11-18 |
2001-05-23 |
Bayer Ag |
GABA-B-Rezeptoren
|
|
EP2180054A1
(en)
|
1999-12-24 |
2010-04-28 |
Genentech, Inc. |
Methods and compositions for prolonging elimination half-times of bioactive compounds
|
|
EP1268554A2
(de)
|
2000-03-31 |
2003-01-02 |
IPF Pharmaceuticals GmbH |
Diagnostik- und arzneimittel zur untersuchung des zelloberflächenproteoms von tumor- und entzündungszellen sowie zur behandlung von tumorerkrankungen und entzündlichen erkrankungen vorzugsweise mit hilfe einer spezifischen chemokinrezeptor-analyse und der chemokinrezeptor-ligand-interaktion
|
|
EP2206720A1
(en)
|
2000-04-12 |
2010-07-14 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
US7943129B2
(en)
|
2000-05-26 |
2011-05-17 |
National Research Council Of Canada |
Single-domain brain-targeting antibody fragments derived from llama antibodies
|
|
US6741957B1
(en)
|
2000-07-21 |
2004-05-25 |
Daimlerchrysler Corporation |
Analytical tire model for vehicle durability and ride comfort analysis
|
|
US7829084B2
(en)
|
2001-01-17 |
2010-11-09 |
Trubion Pharmaceuticals, Inc. |
Binding constructs and methods for use thereof
|
|
AU2002241922B2
(en)
|
2001-01-17 |
2007-10-25 |
Aptevo Research And Development Llc |
Binding domain-immunoglobulin fusion proteins
|
|
US7211395B2
(en)
|
2001-03-09 |
2007-05-01 |
Dyax Corp. |
Serum albumin binding moieties
|
|
EP1379275A4
(en)
|
2001-03-14 |
2005-12-21 |
Centocor Inc |
IMMUNOGLOBULIN-ASSOCIATED PROTEINS ASSOCIATED WITH OBSTRUCTIVE CHRONIC BRONCHOPNEUMOPATHY, COMPOSITIONS, METHODS AND USES
|
|
GB0110029D0
(en)
|
2001-04-24 |
2001-06-13 |
Grosveld Frank |
Transgenic animal
|
|
DK1399484T3
(da)
|
2001-06-28 |
2010-11-08 |
Domantis Ltd |
Dobbelt-specifik ligand og anvendelse af denne
|
|
AU2002355477B2
(en)
|
2001-08-03 |
2008-09-25 |
Medical Research Council |
Method of identifying a consensus sequence for intracellular antibodies
|
|
US20030064053A1
(en)
|
2001-08-31 |
2003-04-03 |
Shengjiang Liu |
Multivalent protein conjugate with multiple ligand-binding domains of receptors
|
|
KR100599789B1
(ko)
|
2001-12-03 |
2006-07-12 |
삼성에스디아이 주식회사 |
방열효율이 향상된 플라즈마 디스플레이 장치 및 그 제조방법
|
|
WO2003055527A2
(en)
|
2002-01-03 |
2003-07-10 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
Immunoconjugates useful for treatment of tumours
|
|
ES2263984T3
(es)
|
2002-06-28 |
2006-12-16 |
Domantis Limited |
Ligandos doble-especificos con una vida media serica aumentada.
|
|
US7004940B2
(en)
|
2002-10-10 |
2006-02-28 |
Ethicon, Inc. |
Devices for performing thermal ablation having movable ultrasound transducers
|
|
US7521543B2
(en)
|
2002-10-23 |
2009-04-21 |
Ludwig Institute For Cancer Research |
A34 and A33-like 3 DNA, proteins, antibodies thereto and methods of treatment using same
|
|
CA2503390A1
(en)
|
2002-11-01 |
2004-05-21 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
WO2004041867A2
(en)
|
2002-11-08 |
2004-05-21 |
Ablynx N.V. |
Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders
|
|
CA2505316C
(en)
|
2002-11-08 |
2014-08-05 |
Ablynx N.V. |
Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
|
|
US7993864B2
(en)
|
2002-12-03 |
2011-08-09 |
Ucb Pharma S.A. |
Assay for identifying antibody producing cells
|
|
GB0228210D0
(en)
|
2002-12-03 |
2003-01-08 |
Babraham Inst |
Single chain antibodies
|
|
US7282568B2
(en)
|
2002-12-16 |
2007-10-16 |
Medarex, Inc. |
Human monoclonal antibodies against interleukin 8 (IL-8)
|
|
GB0230203D0
(en)
|
2002-12-27 |
2003-02-05 |
Domantis Ltd |
Fc fusion
|
|
WO2004060965A2
(en)
|
2002-12-31 |
2004-07-22 |
Nektar Therapeutics Al, Corporation |
Hydrolytically stable maleimide-terminated polymers
|
|
GB0312481D0
(en)
|
2003-05-30 |
2003-07-09 |
Celltech R&D Ltd |
Antibodies
|
|
CN1845938B
(zh)
|
2003-06-30 |
2010-05-26 |
杜门蒂斯有限公司 |
多肽
|
|
ATE554390T1
(de)
|
2003-08-20 |
2012-05-15 |
Ucb Pharma Sa |
Verfahren zur gewinnung von antikörpern
|
|
WO2005103702A2
(en)
|
2004-04-20 |
2005-11-03 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with cxc chemokine receptor 2 (cxcr2)
|
|
US20060008601A1
(en)
|
2004-06-25 |
2006-01-12 |
Zeik Douglas B |
Flexible laminate having an integrated pressure release valve
|
|
US7882839B2
(en)
|
2004-06-25 |
2011-02-08 |
Ambis Jr Edward J |
Custom mouthguard
|
|
SI2311874T1
(sl)
|
2004-07-22 |
2017-12-29 |
Erasmus University Medical Center Rotterdam Department of Cell Biology and Genetics |
Vezavne molekule
|
|
WO2006040153A2
(en)
|
2004-10-13 |
2006-04-20 |
Ablynx N.V. |
Single domain camelide anti -amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenarative neural diseases such as alzheimer's disease
|
|
WO2006040154A2
(en)
|
2004-10-14 |
2006-04-20 |
Dublin City University |
Prokaryotic two hybrid system
|
|
AU2005325801A1
(en)
|
2005-01-31 |
2006-08-03 |
Ablynx N.V. |
Method for generating variable domain sequences of heavy chain antibodies
|
|
WO2006122787A1
(en)
|
2005-05-18 |
2006-11-23 |
Ablynx Nv |
Serum albumin binding proteins
|
|
ES2852423T3
(es)
|
2005-05-20 |
2021-09-13 |
Ablynx Nv |
NanobodiesTM mejorados para el tratamiento de trastornos mediados por agregación
|
|
EP1910828A4
(en)
|
2005-07-01 |
2012-03-14 |
Univ St Louis |
PHOSPHOSPECTIVE CHEMOKIN RECEPTOR ANTIBODIES
|
|
KR20130108481A
(ko)
|
2005-08-19 |
2013-10-02 |
아보트 러보러터리즈 |
이원 가변 도메인 면역글로불린 및 이의 용도
|
|
WO2007112940A2
(en)
|
2006-03-31 |
2007-10-11 |
Ablynx N.V. |
Albumin-derived amino acid sequence, use thereof for increasing the half-life of therapeutic proteins and of other therapeutic compounds and entities, and constructs comprising the same
|
|
EP2010568A1
(en)
|
2006-04-14 |
2009-01-07 |
Ablynx N.V. |
Dp-78-like nanobodies
|
|
CN101070346A
(zh)
*
|
2006-05-08 |
2007-11-14 |
陈正贤 |
一种制备双功能抗体的方法
|
|
WO2008000279A1
(en)
|
2006-06-26 |
2008-01-03 |
Aida Centre, S.L. |
Blister package integrating rfid based tags
|
|
EP2046383B1
(en)
|
2006-07-04 |
2014-11-19 |
Genmab A/S |
Cd20 binding molecules for the treatment of copd
|
|
EP2057191A1
(en)
|
2006-08-18 |
2009-05-13 |
Ablynx N.V. |
Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of deseases and disorders associated with il-6-mediated signalling
|
|
WO2008028044A2
(en)
|
2006-08-30 |
2008-03-06 |
Centocor, Inc. |
Markers and methods for assessing and treating ulcerative colitis and related disorders using 66 gene panel
|
|
CN101646689A
(zh)
|
2006-09-08 |
2010-02-10 |
埃博灵克斯股份有限公司 |
具有长半衰期的血清清蛋白结合蛋白
|
|
US20100034194A1
(en)
|
2006-10-11 |
2010-02-11 |
Siemens Communications Inc. |
Eliminating unreachable subscribers in voice-over-ip networks
|
|
WO2008043821A1
(en)
|
2006-10-11 |
2008-04-17 |
Ablynx N. V. |
Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the ph, compounds comprising the same, and use thereof
|
|
WO2008074839A2
(en)
|
2006-12-19 |
2008-06-26 |
Ablynx N.V. |
Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders
|
|
KR20090123857A
(ko)
|
2007-02-22 |
2009-12-02 |
노보 노르디스크 헬스 케어 악티엔게젤샤프트 |
특이성이 개선된 트랜스글루타미나아제 변이체
|
|
EP2185188B1
(en)
|
2007-08-22 |
2014-08-06 |
Medarex, L.L.C. |
Site-specific attachment of drugs or other agents to engineered antibodies with c-terminal extensions
|
|
US20110183861A1
(en)
|
2008-01-29 |
2011-07-28 |
Ablynn N.V. |
Methods to stabilize proteins and polypeptides
|
|
NZ589036A
(en)
|
2008-05-16 |
2012-07-27 |
Ablynx Nv |
AMINO ACID SEQUENCES DIRECTED AGAINST CXCR4 AND OTHER GPCRs AND COMPOUNDS COMPRISING THE SAME
|
|
EP2352764B1
(en)
|
2008-10-14 |
2018-03-28 |
Ablynx N.V. |
AMINO ACID SEQUENCES TARGETING HUMAN CD4 and CXCR4, CCR5, TLR4, ALPHAV INTEGRIN, BETA3-INTEGRIN,BETA1-INTEGRIN, HUMAN ALPHA2-INTEGRIN, CD81, SR-BI, CLAUDIN-1, CLAUDIN-6 AND/OR CLAUDIN-9, RESPECTIVELY, AND NEUTRALIZING VIRAL ENTRY
|
|
EP3181583A1
(en)
|
2009-02-24 |
2017-06-21 |
ESBATech, an Alcon Biomedical Research Unit LLC |
Methods for identifying immunobinders of antigens
|
|
HUE051430T2
(hu)
|
2009-07-10 |
2021-03-01 |
Ablynx Nv |
Eljárás variábilis domének elõállítására
|
|
AU2010298249A1
(en)
|
2009-09-23 |
2012-04-19 |
Carolus Therapeutics, Inc. |
Methods of treating inflammation
|
|
PT2513147T
(pt)
|
2009-12-18 |
2016-10-11 |
Sanofi Sa |
Novos anticorpos antagonistas e seus fragmentos fab contra gpvi e utilizações destes
|
|
CA2777527C
(en)
|
2009-12-23 |
2020-06-23 |
Esbatech, An Alcon Biomedical Research Unit Llc |
Method for decreasing immunogenicity
|
|
WO2011083141A2
(en)
*
|
2010-01-08 |
2011-07-14 |
Ablynx Nv |
Method for generation of immunoglobulin sequences by using lipoprotein particles
|
|
EA202092589A3
(ru)
|
2010-11-08 |
2021-06-30 |
Аблинкс Н.В. |
Cxcr2-связывающие полипептиды
|
|
DK2723769T4
(da)
|
2011-06-23 |
2022-09-05 |
Ablynx Nv |
Teknikker til at forudsige, påvise og reducere uspecifik proteininterferens i assays, som involverer variable immunglobulin-enkeltdomæner
|
|
SG2014010482A
(en)
|
2011-08-17 |
2014-04-28 |
Glaxo Group Ltd |
Modified proteins and peptides
|
|
US9328174B2
(en)
|
2012-05-09 |
2016-05-03 |
Novartis Ag |
Chemokine receptor binding polypeptides
|
|
EP3087394A2
(en)
|
2013-12-27 |
2016-11-02 |
Merrimack Pharmaceuticals, Inc. |
Biomarker profiles for predicting outcomes of cancer therapy with erbb3 inhibitors and/or chemotherapies
|